SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Vasiliki Katsi, Ioannis Felekos, Stamatios Skevofilax, Constantina Aggeli, Dimitris Tousoulis, Christodoulos Stefanadis, Ioannis Kallikazaros, Cardiovascular Disease and Hepatitis C Virus Infection, Cardiology in Review, 2015, 23, 1, 11

    CrossRef

  2. 2
    Dalia A. Omran, Noha Hosam E.L. Din Behairy, Khaled Serag Zakaria, Mohamed Mahmoud Nabil, Karim Said, Functional and morphological myocardial changes in hepatitis C virus patients with end-stage liver disease, Scandinavian Journal of Gastroenterology, 2015, 1

    CrossRef

  3. 3
    Yueh-Han Hsu, Chih-Hsin Muo, Chun-Yi Liu, Wen-Chen Tsai, Chih-Cheng Hsu, Fung-Chang Sung, Chia-Hung Kao, Hepatitis C virus infection increases the risk of developing peripheral arterial disease: A 9-year population-based cohort study, Journal of Hepatology, 2015, 62, 3, 519

    CrossRef

  4. 4
    Daniel Pineda-Tenor, Juan Berenguer, María A. Jiménez-Sousa, Ana Carrero, Mónica García-Álvarez, Teresa Aldámiz-Echevarria, Pilar García-Broncano, Cristina Diez, María Guzmán-Fulgencio, Amanda Fernández-Rodríguez, Salvador Resino, rs7903146 Polymorphism atTranscription Factor 7 Like 2Gene Is Associated with Total Cholesterol and Lipoprotein Profile in HIV/Hepatitis C Virus-Coinfected Patients, AIDS Research and Human Retroviruses, 2015, 31, 3, 326

    CrossRef

  5. 5
    Viktor V Chirikov, Fadia T Shaya, Charles D Howell, Association between interferon use and reduced metabolic and vascular complications among patients with hepatitis C, Expert Review of Gastroenterology & Hepatology, 2014, 8, 8, 973

    CrossRef

  6. 6
    Daniel Pineda-Tenor, Juan Berenguer, Pilar García-Broncano, María A. Jiménez-Sousa, Amanda Fernández-Rodríguez, Cristina Diez, Mónica García–Álvarez, Ana Carrero, Pilar Catalán, Teresa Aldámiz-Echevarria, Salvador Resino, Association of adiponectin (ADIPOQ) rs2241766 polymorphism and dyslipidemia in HIV/HCV-coinfected patients, European Journal of Clinical Investigation, 2014, 44, 5
  7. 7
    S. Petta, F. S. Macaluso, A. Craxi, Cardiovascular diseases and HCV infection: a simple association or more?, Gut, 2014, 63, 3, 369

    CrossRef

  8. 8
    Francesco Negro, Facts and fictions of HCV and comorbidities: Steatosis, diabetes mellitus, and cardiovascular diseases, Journal of Hepatology, 2014, 61, 1, S69

    CrossRef

  9. 9
    Robert J. Wong, Fasiha Kanwal, Zobair M. Younossi, Aijaz Ahmed, Hepatitis C Virus Infection and Coronary Artery Disease Risk: A Systematic Review of the Literature, Digestive Diseases and Sciences, 2014, 59, 7, 1586

    CrossRef

  10. 10
    Linda Henry, Zobair Younossi, Hepatitis: Chronic HCV infection, diabetes and liver-related outcomes, Nature Reviews Gastroenterology and Hepatology, 2014, 11, 9, 520

    CrossRef

  11. 11
    M. A. Jiménez-Sousa, J. Berenguer, A. Fernández-Rodríguez, D. Micheloud, M. Guzmán-Fulgencio, P. Miralles, D. Pineda-Tenor, M. García–Álvarez, J. C. López, T. Aldámiz-Echevarria, A. Carrero, S. Resino, IL28RA polymorphism (rs10903035) is associated with insulin resistance in HIV/HCV-coinfected patients, Journal of Viral Hepatitis, 2014, 21, 3
  12. 12
    R. Mahajan, J. Xing, S. J. Liu, K. N. Ly, A. C. Moorman, L. Rupp, F. Xu, S. D. Holmberg, S. D. Holmberg, E. H. Teshale, P. R. Spradling, A. C. Moorman, S. C. Gordon, D. R. Nerenz, M. Lu, L. Lamerato, L. B. Rupp, N. Akkerman, N. Oja-Tebbe, C. M. Cogan, D. Larkin, J. A. Boscarino, Z. S. Daar, J. B. Leader, R. E. Smith, C. C. Nakasato, V. Vijayadeva, K. E. Sylva, J. V. Parker, M. M. Schmidt, M. A. Schmidt, J. L. Donald, E. M. Keast, Mortality Among Persons in Care With Hepatitis C Virus Infection: The Chronic Hepatitis Cohort Study (CHeCS), 2006-2010, Clinical Infectious Diseases, 2014, 58, 8, 1055

    CrossRef

  13. 13
    Pilar García-Broncano, Juan Berenguer, Amanda Fernández-Rodríguez, Daniel Pineda-Tenor, María Jiménez-Sousa, Mónica García–Alvarez, Pilar Miralles, Teresa Aldámiz-Echevarria, Juan López, Dariela Micheloud, Salvador Resino, PPARγ2 Pro12Ala polymorphism was associated with favorable cardiometabolic risk profile in HIV/HCV coinfected patients: a cross-sectional study, Journal of Translational Medicine, 2014, 12, 1, 235

    CrossRef

  14. 14
    Constance E. Ruhl, Andy Menke, Catherine C. Cowie, James E. Everhart, Relationship of hepatitis C virus infection with diabetes in the U.S. population, Hepatology, 2014, 60, 4
  15. 15
    J. Ampuero, M. Romero-Gómez, K. R. Reddy, Review article: HCV genotype 3 – the new treatment challenge, Alimentary Pharmacology & Therapeutics, 2014, 39, 7
  16. 16
    Daniel Pineda-Tenor, Dariela Micheloud, Juan Berenguer, María A. Jiménez-Sousa, Amanda Fernández-Rodríguez, Pilar García-Broncano, María Guzmán-Fulgencio, Cristina Diez, José M. Bellón, Ana Carrero, Teresa Aldámiz-Echevarria, Mónica García-Álvarez, Salvador Resino, SLC30A8 rs13266634 polymorphism is related to a favorable cardiometabolic lipid profile in HIV/hepatitis C virus-coinfected patients, AIDS, 2014, 28, 9, 1325

    CrossRef

  17. 17
    Z. M. Younossi, F. Kanwal, S. Saab, K. A. Brown, H. B. El-Serag, W. R. Kim, A. Ahmed, M. Kugelmas, S. C. Gordon, The impact of hepatitis C burden: an evidence-based approach, Alimentary Pharmacology & Therapeutics, 2014, 39, 5
  18. 18
    Nicolas Goossens, Francesco Negro, The Impact of Obesity and Metabolic Syndrome on Chronic Hepatitis C, Clinics in Liver Disease, 2014, 18, 1, 147

    CrossRef

  19. 19
    Amr Hany Metwally, Mohamed-Adel F. Elgamal, The relation between hepatitis C virus and coronary heart disease, Medical Hypotheses, 2014, 82, 4, 505

    CrossRef

  20. 20
    Fabrizio Fabrizi, Piergiorgio Messa, Paul Martin, The Unravelled Link between Chronic Kidney Disease and Hepatitis C Infection, New Journal of Science, 2014, 2014, 1

    CrossRef

  21. 21
    Cheryl Enger, Ulla M. Forssen, Dimitri Bennett, Dickens Theodore, Sumitra Shantakumar, Andrew McAfee, Thromboembolic Events Among Patients with Hepatitis C Virus Infection and Cirrhosis: A Matched-Cohort Study, Advances in Therapy, 2014, 31, 8, 891

    CrossRef

  22. 22
    Francesco Negro, Hepatitis C in 2013: HCV causes systemic disorders that can be cured, Nature Reviews Gastroenterology & Hepatology, 2013, 11, 2, 77

    CrossRef

  23. You have free access to this content23
    S. C. Gordon, F. M. Hamzeh, P. J. Pockros, R. S. Hoop, A. R. Buikema, E. J. Korner, N. A. Terrault, Hepatitis C virus therapy is associated with lower health care costs not only in noncirrhotic patients but also in patients with end-stage liver disease, Alimentary Pharmacology & Therapeutics, 2013, 38, 7
  24. 24
    Fabio Salvatore Macaluso, Marcello Maida, Maria Giovanna Minissale, Teresa Li Vigni, Simona Attardo, Emanuele Orlando, Salvatore Petta, Metabolic Factors and Chronic Hepatitis C: A Complex Interplay, BioMed Research International, 2013, 2013, 1

    CrossRef

  25. 25
    Jerzy Jaroszewicz, Robert Flisiak, Metabolic syndrome and hepatitis C infection – brothers in arms, Liver International, 2013, 33, 8